Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

Journal of Virology

Volumn 74, Issue 6, 2000, Pages 2777-2785

  Bartlett, Jeffrey S ^a,b,c   Wilcher, Rose ^a   Samulski, R Jude ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM CHLORIDE; BAFILOMYCIN A1; DYNAMIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; ENDOCYTOSIS; ENDOSOME; GENE TRANSFER; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS PARTICLE;

ACIDS; ADENOVIRIDAE; BIOLOGICAL TRANSPORT; CARBOCYANINES; CELL LINE, TRANSFORMED; CELL NUCLEUS; CLATHRIN; COATED PITS, CELL-MEMBRANE; DEPENDOVIRUS; ENDOCYTOSIS; ENDOSOMES; FLUORESCENT DYES; GENETIC VECTORS; HELA CELLS; HUMANS;

EID: 0033998692     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.6.2777-2785.2000     Document Type: Article

References (49)

1. Bartlett, J. S., and R. J. Samulski. 1998. Fluorescent viral vectors: a new technique for the pharmacological analysis of gene therapy. Nat. Med. 4: 635-637.
2. Bartlett, J. S., R. J. Samulski, and T. J. McCown. 1998. Selective and rapid uptake of adeno-associated virus type-2 (AAV-2) in brain. Hum. Gene Ther. 9:1181-1186.
3. Basak, S., H. Turner, and S. Parr. 1994. Identification of a 40-to 42-kDa attachment polypeptide for canine parvovirus in A72 cells. Virology 205: 7-16.
4. Basak, S., and H. Turner. 1992. Infectious entry pathway for canine parvo-virus. Virology 186:368-376.
5. Bayer, N., D. Schober, E. Prchla, R. F. Murphy, D. Blaas, and R. Fuchs. 1998. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J. Virol. 72:9645-9655.
6. Bowman, E. J., A. Siebers, and K. Altendorf. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA 85:7972-7976.
7. vβ5 integrin. J. Virol. 73:6759-6768.
8. Clark, K. R., X. Liu, J. P. McGrath, and P. R. Johnson. 1999 Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum. Gene Ther. 10:1031-1039.
9. Damke, H., T. Baba, D. E. Warnock, and S. L. Schmid. 1994. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J. Cell Biol. 127:915-934.
10. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
11. Fisher, K. J., G.-P. Gao, M. D. Weitzman, R. DeMatteo, J. F. Burda, and J. M. Wilson. 1996. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70:520-532.
12. Gey, G. O., W. D. Coffman, and M. T. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12L:264.
13. Goodman, S., X. Xiao, R. E. Donahue, A. Moulton, J. Miller, C. Walsh, N. S. Young, R. J. Samulski, and A. W. Nienhuis. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500.
14. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
15. Greber, U. F., M. Y. Nakano, and M. Suomalainen. 1998. Adenovirus entry into cells. A quantitative fluorescence microscopy approach, p. 217-230. In W. S. M. Wold (ed.), Adenovirus methods and protocols, vol. 21. Humana Press, Inc., Totowa, N.J.
16. Greber, U. F., M. Suomalainen, R. P. Stidwill, K. Boucke, M. W. Ebersold, and A. Helenius. 1997. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16:5998-6007.
17. Halbert, C. L., T. A. Standaert, M. L. Aitken, I. E. Alexander, D. W. Russell, and A. D. Miller. 1997. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol. 71:5932-5941.
18. Hinshaw, J. E., and S. L. Schmid. 1995. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding. Nature 374:190-192.
19. Jones, N., and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
20. Kaljot, K. T., R. D. Shaw, D. H. Rubin, and H. B. Greenberg. 1988. Infectious rotavirus enters cells by direct cell membrane penetration, not by endocytosis. J. Virol. 62:1136-1144.
21. Lamaze, C., and S. L. Schmid. 1995. The emergence of clathrin-independent pinocytic pathways. Curr. Opin. Cell Biol. 7:573-580.
22. Leopold, P. L., B. Ferris, I. Grinberg, S. Worgall, N. R. Hackett, and R. G. Crystal. 1998. Fluorescent virions: dynamic trafficking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9:367-378.
23. Li, J., R. J. Samulski, and X. Xiao. 1997. Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71:5236-5243.
24. Linser, P., H. Bruning, and R. W. Armentrout. 1977. Specific binding sites for a parvovirus, minute virus of mice, on cultured mouse cells. J. Virol. 24: 211-221.
25. Madshus, I. H., S. Olsner, and K. Sandvig. 1984. Mechanism of entry into the cytosol of poliovirus type 1: requirement of low pH. J. Cell Biol. 98: 1194-1200.
26. Mizukami, H., N. S. Young, and K. E. Brown. 1996. Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology 217: 124-130.
27. Mukherjee, S., R. N. Ghosh, and F. R. Maxfield. 1997 Endocytosis. Physiol. Rev. 77:759-803.
28. Ohkuma, S., and B. Poole. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327-3331.
29. Pastan, I., P. Seth, D. Fitzgerald, and M. Willingham. 1986. Adenovirus entry into cells: some new observations on an old problem, p. 141-146. In L. Notkin and M. B. A. Oldstone (ed.). Concepts in viral pathogenesis II. Springer-Verlag, New York, N.Y.
30. Qing, K., C. Mah, J. Hansen, S. Zhou, V. Dwarki, and A. Srivastava. 1999. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5:71-77.
31. Qing, K., B. Khuntirat, C. Mah, D. M. Kube, X.-S. Wang, S. Ponnazhagan, S. Zhou, V. J. Dwarki, M. C. Yoder, and A. Srivastava. 1998. Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72:1593-1599.
32. Ramaswamy, H., and M. E. Hemler. 1990. Cloning, primary structure and properties of a novel human integrin beta subunit. EMBO J. 9:1561-1568.
33. Rose, J. A., and F. Koczot. 1972. Adenovirus-associated virus multiplication. VII. Helper requirement for viral deoxyribonucleic acid and ribonucleic acid synthesis. J. Virol. 10:1-8.
34. Samulski, R. J., L.-S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
35. Samulski, R. J., L.-S. Chang, and T. Shenk. 1987. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:3096-3101.
36. Samulski, R. J., M. Sally, and N. Muzjczka. 1999. Adeno-associated viral vectors, p. 131-172. In T. Friedmann (ed.), The development of human gene therapy. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Sanes, J. R., J. L. R. Rubenstein, and J. F. Nicolas. 1986. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:3133-3142.
38. Snyder, R. O., X. Xiao, and R. J. Samulski. 1996. Production of recombinant adeno-associated virus vectors, p. 12.1.1-12.2.23. In N. Dracopoli, J. Haines, B. Krof, D. Moir, C. Seidman, J. S. Seidman (ed.). Current protocols in human genetics. John Wiley & Sons, New York, N.Y.
39. Sturzenbecker, L. J., M. Nibert, D. Furlong, and B. N. Fields. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61:2351-2361.
40. vβ5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5:78-82.
41. Summerford, C., and R. J. Samulski. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
42. Suzuki, S., W. S. Argraves, R. Pytela, H. Arai, T. Krusius, M. D. Pierschbacher, and E. Ruoslahti. 1986. cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc. Natl. Acad. Sci. USA 83:8614-8618.
43. Takei, K., P. S. McPherson, S. L. Schmid, and P. D. Camilli. 1995. Tubular membrane invaginations coated by dynamin rings are induced by GTP-γS in nerve terminals. Nature 374:186-190.
44. Teramoto, S., J. S. Bartlett, D. McCarty, X. Xiao, R. J. Samulski, and R. C. Boucher. 1998. Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: comparison with adenovirus vectors. J. Virol. 72:8904-8912.
45. Varga, M. J., C. Weibull, and E. Everitt. 1991. Infectious entry pathway of adenovirus type 2. J. Virol. 65:6061-6070.
46. Wang, K., S. Huang, A. Kapoor-Munshi, and G. Nemerow. 1998. Adenovirus internalization and infection require dynamin. J. Virol. 72:3455-3458.
47. vβ5 selectively promotes adenovirus-mediated cell membrane permeabilizalion. J. Cell Biol. 127:257-264.
48. Zeichhardt, H., K. Wertz, P. Willingman, and K.-O. Habermehl. 1985. Entry of poliovirus type 1 and mouse Elberfeld (ME) virus into HEp-2 cells: receptor-mediated endocytosis and endosomal or lysosomal uncoating. J. Gen. Virol. 66:483-492.
49. Zolotukhin, S. 1999. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6:973-985.